0000927066-17-000003.txt : 20170615 0000927066-17-000003.hdr.sgml : 20170615 20170615175950 ACCESSION NUMBER: 0000927066-17-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170613 FILED AS OF DATE: 20170615 DATE AS OF CHANGE: 20170615 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JIGANTI JEANINE MARIE CENTRAL INDEX KEY: 0001566865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 17914414 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 4 1 wf-form4_149756397456297.xml FORM 4 X0306 4 2017-06-13 0 0000927066 DAVITA INC. DVA 0001566865 JIGANTI JEANINE MARIE C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 0 1 0 0 Chief Compliance Officer Common Stock 2017-06-13 4 M 0 7500 53.16 A 11014 D Common Stock 2017-06-13 4 M 0 5200 58.94 A 16214 D Common Stock 2017-06-13 4 F 0 10814 65.22 D 5400 D Common Stock 2017-06-13 4 S 0 1886 65.5698 D 3514 D Stock Appreciation Rights 53.16 2017-06-13 4 M 0 7500 53.16 D 2015-12-05 2017-12-05 Common Stock 7500.0 0 D Stock Appreciation Rights 58.94 2017-06-13 4 M 0 5200 58.94 D 2016-03-19 2019-03-19 Common Stock 5200.0 0 D Represents the weighted average sale price of $65.5698. The range of prices for the sale of these shares was $65.5500-$65.5900, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The Stock Appreciation Rights were granted on 12/05/2012. 50% vested on 12/05/2015 and the remaining 50% vested on 12/05/2016. The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% vested on 3/19/2017. /s/ Arturo Sida, Attorney-in-Fact 2017-06-14